 pregnancy-induc chang drug metabol epilept women pharmacokinet antiepilept drug pregnanc declin serum concentr subsequ suboptim control seizur chang pregnanc hepat drug handl metabol ratio pregnant epilept women nonpregn epilept women pregnant nonepilept nonpregn nonepilept control caffein test sever enzym activ xanthin oxidas n-acetyltransferas hydroxyl end ratio number metabolit main demethyl pathway caffein addit d-glucar acid excret specif character antiepilept drug metabol pair comparison epilept women late pregnanc week post partum signific decreas xanthin oxidas n-acetyltransferas activ hydroxyl activ pregnanc epilept women fast acetyl normal distribut nonepilept control group excret d-glucar acid epilept patient group nonepilept control group pregnant nonepilept control group nonpregn nonepilept women overal result enzymat pathway antiepilept drug metabol pregnanc potenti caus observ serum concentr drug